Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.
about
Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a reviewVitamin D—update for the pediatric rheumatologistsSerum pharmacodynamic biomarkers for chronic corticosteroid treatment of children.Update on Bone Health in Pediatric Chronic Disease.Management considerations for childhood-onset systemic lupus erythematosus patients and implications on therapy.Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.Effects of the use of growth hormone in children and adolescents with juvenile idiopathic arthritis: a systematic review.Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.Bone modeling, remodeling, and skeletal health in children and adolescents: mineral accrual, assessment and treatment.Bone status assessed by quantitative ultrasound in children with inflammatory bowel disease: a comparison with DXA.GLUCOCORTICOID-INDUCED BONE DISEASE: MECHANISMS AND IMPORTANCE IN PEDIATRIC PRACTICE.Mepolizumab-a novel option for the treatment of hypereosinophilic syndrome in childhood.Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study.Risk factors for nonunion of bone fracture in pediatric patients: An inception cohort study of 237,033 fractures
P2860
Q28066474-625F736F-4BAF-4A86-A9AE-6B910D28EC4AQ30375070-B3E8EF66-E13B-4B3A-A9B3-454F45D14649Q37181580-119E57EB-3CE3-40D2-8C21-A0BBFCE175B3Q37612807-7950DE0D-EDEF-4BC1-BA84-F9112633CA51Q38640910-15901F7C-9749-4F43-9AE1-877210D6C486Q38692553-53B046B5-4D96-44C3-BA29-A08F42DDDC14Q39170493-E8DD625E-8264-4A20-A9C7-CE52C6FF690EQ39177137-454606FF-39CD-4F42-AD51-2D042996C2CDQ39262959-1F5DACE0-7D70-45DE-8925-67E736132FECQ39345817-5317DC0A-5F2C-463E-9BA3-E1C4F82DDF3EQ42955401-B242A510-81A8-4152-9E9A-6F0B50A9CF66Q48229585-76E740E5-25DA-4AA6-A753-6F077196C334Q55359429-586834D1-8D58-4FFC-86F3-F04E310E8D1DQ58801984-3CBB6988-C2E6-4E02-A040-CEBDF31C7ECE
P2860
Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Glucocorticoid-associated oste ...... sms, diagnosis, and treatment.
@en
type
label
Glucocorticoid-associated oste ...... sms, diagnosis, and treatment.
@en
prefLabel
Glucocorticoid-associated oste ...... sms, diagnosis, and treatment.
@en
P2860
P1476
Glucocorticoid-associated oste ...... sms, diagnosis, and treatment.
@en
P2093
Emily von Scheven
Kathleen Jo Corbin
P2860
P2888
P304
P356
10.1007/S11914-014-0228-X
P577
2014-09-01T00:00:00Z
P5875
P6179
1032852543